Karen M Mattia

Title: Karen M Mattia: Innovator in Chemokine Receptor Antagonists

Introduction

Karen M Mattia is a prominent inventor based in Marlborough, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of chemokine receptor antagonists. With a total of 5 patents to her name, her work has the potential to impact the treatment of diseases associated with aberrant leukocyte recruitment and activation.

Latest Patents

Among her latest patents, two notable inventions include methods for treating diseases related to aberrant leukocyte recruitment and activation. The first patent discloses novel compounds and a method of administering an effective amount of a compound or its physiologically acceptable salt to a subject in need. The second patent similarly focuses on chemokine receptor antagonists and outlines methods of use for these compounds in treating related diseases.

Career Highlights

Throughout her career, Karen has worked with esteemed companies such as Millennium Pharmaceuticals Limited and Kyowa Hakko Kirin Co., Limited. Her experience in these organizations has allowed her to refine her expertise in pharmaceutical innovations and contribute to groundbreaking research.

Collaborations

Karen has collaborated with notable professionals in her field, including Jay R Luly and Yoshisuke Nakasato. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Karen M Mattia stands out as an influential inventor in the realm of chemokine receptor antagonists. Her innovative work and collaborations continue to pave the way for advancements in medical treatments.